Ignite Creation Date:
2024-05-05 @ 12:06 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00246662
Status:
COMPLETED
Last Update Posted:
2017-03-30
First Post:
2005-06-30
Brief Title:
Safety Assessment of Two Schedules of Intravenous Infusions of SNS-595 for the Treatment of Hematologic Malignancies
Sponsor:
Sunesis Pharmaceuticals
Organization:
Sunesis Pharmaceuticals
Organization Data
Organization:
Sunesis Pharmaceuticals
Class:
INDUSTRY
Study ID:
SPO-0004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sunesis Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None